The DOI matches its Crossref record; 42 of the 42 references it cites were found in a registry or an index.
Prior Multiple Ethanol Withdrawals Enhance Stress-Induced Anxiety-Like Behavior: Inhibition by CRF1- and Benzodiazepine-Receptor Antagonists and a 5-HT1a-Receptor Agonist
Open accessAbstract
Repeated withdrawals from chronic ethanol induce a persistent adaptive change. Further, stress substitutes for the initial two withdrawals of a multiple-withdrawal protocol to sensitize rats to withdrawal-induced anxiety-like behavior ('anxiety'). Therefore, it was tested whether the persistent adaptation induced by multiple-withdrawal exposures allows stress to elicit anxiety after a period of abstinence. Social interaction was used to assess the degree of anxiety induced by 45 min of restraint stress 3, 7, or 14 days after rats were exposed to multiple withdrawals from a chronic 4.5% ethanol diet. Restraint stress reduced social interaction (ie anxiety-like behavior) at 3, but not at 7 or 14 days, after the multiple withdrawals. No anxiety response was observed in animals that received multiple withdrawals without stress or in animals that received stress when exposed only to control liquid diet. Drugs (ie a CRF1-receptor antagonist, a benzodiazepine receptor antagonist, and a 5-HT1A-receptor agonist) previously demonstrated to block the cumulative adaptation, when administered during repeated withdrawals, prevented stress-induced anxiety-like behavior during abstinence. Additionally, these drugs applied prior to stress in the rats previously exposed to the repeated withdrawal protocol, likewise, minimized stress-induced anxiety. The anxiety following stress during abstinence from previous chronic ethanol exposure is indicative of an interaction of stress with the persistent adaptive change caused by repeated withdrawals. Stress eliciting anxiety-like behavior during abstinence from previous ethanol exposures in rats is consistent with stress inducing anxiety during recovery (sobriety) in the alcoholic, a circumstance that can facilitate craving and relapse.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The cited source says what the claim attributes to it.
In the citing paper
“Systemic CRF 1 receptor antagonist administration blocked anxiety-like responses to alcohol withdrawal (Knapp et al., 2004;Overstreet et al., 2004b;Breese et al., 2005).”
From Drug Addiction: Hyperkatifeia/Negative Reinforcement as a Framework for Medications Development (2021) · cites this paper as Breese et al., 2005
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
How does stress increase risk of drug abuse and relapse?
Sinha, R. (2001) · Psychopharmacology · doi:10.1007/s002130100917 · Cited by 1,505
File, S. E. (1980) · Journal of Neuroscience Methods · doi:10.1016/0165-0270(80)90012-6 · Cited by 820
CAN SOCIAL INTERACTION BE USED TO MEASURE ANXIETY?
File, S. E., & Hyde, J. R. G. (1978) · British Journal of Pharmacology · doi:10.1111/j.1476-5381.1978.tb07001.x · Cited by 808
A review of 25 years of the social interaction test
File, S. E., & Seth, P. (2003) · European Journal of Pharmacology · doi:10.1016/s0014-2999(03)01273-1 · Cited by 763
Alcohol cue reactivity, negative-mood reactivity, and relapse in treated alcoholic men.
Cooney, N. L., Litt, M. D., Morse, P. A., Bauer, L. O., & al, E. (1997) · Journal of Abnormal Psychology · doi:10.1037//0021-843x.106.2.243 · Cited by 479
Alcohol cue reactivity, negative-mood reactivity, and relapse in treated alcoholic men.
Cooney, N. L., Litt, M. D., Morse, P. A., Bauer, L. O., & Gaupp, L. (1997) · Journal of Abnormal Psychology · doi:10.1037/0021-843x.106.2.243 · Cited by 479
Rassnick, S., Heinrichs, S. C., Britton, K. T., & Koob, G. F. (1993) · Brain Research · doi:10.1016/0006-8993(93)91352-s · Cited by 407
Valdez, G. R., Roberts, A. J., Chan, K., Davis, H., Brennan, M., Zorrilla, E. P., & Koob, G. F. (2002) · Alcoholism: Clinical and Experimental Research · doi:10.1111/j.1530-0277.2002.tb02448.x · Cited by 387
Stress, vulnerability and adult alcohol relapse.
Brown, S. A., Vik, P. W., Patterson, T. L., Grant, I., & Schuckit, M. A. (1995) · Journal of Studies on Alcohol · doi:10.15288/jsa.1995.56.538 · Cited by 380
Stress and Alcohol Interaction: An Update of Human Research
Pohorecky, L. A. (1991) · Alcoholism Clinical and Experimental Research · doi:10.1111/j.1530-0277.1991.tb00543.x · Cited by 341
Flagged first, then by citations
Research works printed but not linked: 2
- Knapp DJ, Angel RA, Overstreet DH, Breese GR (2004a). The prophylactic effects of flumazenil on repeated ethanol withdrawal-induced anxiety are mediated by the amygdala. Alcohol Clin Exp Res 28: 142A.
- Overstreet DH, Knapp DJ, Breese GR (2004a). Brain site-selective effects of 5-HT1A agonist and 5-HT2C antagonist on ethanol withdrawal induced anxiety. Alcohol Clin Exp Res 28: 64A.
Cited by
Sorted by citations
A Role for Brain Stress Systems in Addiction
Koob, G. F. (2008) · Neuron · doi:10.1016/j.neuron.2008.06.012 · Cited by 1,056
A key role for corticotropin-releasing factor in alcohol dependence
Heilig, M., & Koob, G. F. (2007) · Trends in Neurosciences · doi:10.1016/j.tins.2007.06.006 · Cited by 503
Addiction as a stress surfeit disorder
Koob, G. F., Buck, C. L., Cohen, A., Edwards, S., Park, P. E., Schlosburg, J. E., Schmeichel, B., Vendruscolo, L. F., Wade, C. L., Whitfield, T. W., et al. (2014) · Neuropharmacology · doi:10.1016/j.neuropharm.2013.05.024 · Cited by 483
Role of Corticotropin-Releasing Factor in Drug Addiction
Logrip, M. L., Koob, G. F., & Zorrilla, E. P. (2011) · CNS Drugs · doi:10.2165/11587790-000000000-00000 · Cited by 474
Neurobiological substrates for the dark side of compulsivity in addiction
Koob, G. F. (2008) · Neuropharmacology · doi:10.1016/j.neuropharm.2008.07.043 · Cited by 475
REVIEW: Acute withdrawal, protracted abstinence and negative affect in alcoholism: are they linked?
Heilig, M., Egli, M., Crabbe, J. C., & Becker, H. C. (2010) · Addiction Biology · doi:10.1111/j.1369-1600.2009.00194.x · Cited by 435
Koob, G. F. (2011) · Current topics in behavioral neurosciences · doi:10.1007/7854_2011_129 · Cited by 449
Addiction is a Reward Deficit and Stress Surfeit Disorder
Koob, G. F. (2013) · Frontiers in Psychiatry · doi:10.3389/fpsyt.2013.00072 · Cited by 397
Brain stress systems in the amygdala and addiction
Koob, G. F. (2009) · Brain Research · doi:10.1016/j.brainres.2009.03.038 · Cited by 388
Alcohol dependence as a chronic pain disorder
Egli, M., Koob, G. F., & Edwards, S. (2012) · Neuroscience & Biobehavioral Reviews · doi:10.1016/j.neubiorev.2012.07.010 · Cited by 347
Drug Addiction: Hyperkatifeia/Negative Reinforcement as a Framework for Medications Development
Koob, G. F. (2021) · Pharmacological Reviews · doi:10.1124/pharmrev.120.000083 · Cited by 337
Sommer, W. H., Rimondini, R., Hansson, A. C., Hipskind, P. A., Gehlert, D. R., Barr, C. S., & Heilig, M. A. (2008) · Biological Psychiatry · doi:10.1016/j.biopsych.2007.01.010 · Cited by 309
Disrupted Ventromedial Prefrontal Function, Alcohol Craving, and Subsequent Relapse Risk
Seo, D., Lacadie, C., Tuit, K. L., Hong, K., Constable, R. T., & Sinha, R. (2013) · JAMA Psychiatry · doi:10.1001/jamapsychiatry.2013.762 · Cited by 316
The role of CRF and CRF-related peptides in the dark side of addiction
Koob, G. F. (2009) · Brain Research · doi:10.1016/j.brainres.2009.11.008 · Cited by 301
Breese, G. R., Sinha, R., & Heilig, M. A. (2010) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2010.09.007 · Cited by 274
Self-citationCorticotropin releasing factor: A key role in the neurobiology of addiction
Zorrilla, E. P., Logrip, M. L., & Koob, G. F. (2014) · Frontiers in Neuroendocrinology · doi:10.1016/j.yfrne.2014.01.001 · Cited by 267
Pharmacogenetic approaches to the treatment of alcohol addiction
Heilig, M. A., Goldman, D. A., Berrettini, W. H., & O’Brien, C. P. (2011) · Nature reviews. Neuroscience · doi:10.1038/nrn3110 · Cited by 256
Dynamics of Neuronal Circuits in Addiction: Reward, Antireward, and Emotional Memory
Koob, G. F. (2009) · Pharmacopsychiatry · doi:10.1055/s-0029-1216356 · Cited by 254
Effects of stress on alcohol drinking: a review of animal studies
Becker, H. C., Lopez, M. F., & Doremus‐Fitzwater, T. L. (2011) · Psychopharmacology · doi:10.1007/s00213-011-2443-9 · Cited by 246
Gehlert, D. R., Cippitelli, A., Thorsell, A., Lê, A. D., Hipskind, P. A., Hamdouchi, C., Lu, J., Hembre, E. J., Cramer, J. W., Song, M., et al. (2007) · Journal of Neuroscience · doi:10.1523/jneurosci.4985-06.2007 · Cited by 239
Neurocircuitry of alcohol addiction
Koob, G. F. (2014) · Handbook of clinical neurology · doi:10.1016/b978-0-444-62619-6.00003-3 · Cited by 238
Influence of stress associated with chronic alcohol exposure on drinking
Becker, H. C. (2017) · Neuropharmacology · doi:10.1016/j.neuropharm.2017.04.028 · Cited by 191
Marinelli, P. W., Funk, D. R., Juzytsch, W., Harding, S. E., Rice, K. C., Shaham, Y., & Lê, A. D. (2007) · Psychopharmacology · doi:10.1007/s00213-007-0905-x · Cited by 191
Alcohol Dependence, Withdrawal, and Relapse
Becker, H. C. (2014) · Elsevier eBooks · doi:10.1016/b978-0-12-405941-2.00019-5 · Cited by 188
Effects of alcohol dependence and withdrawal on stress responsiveness and alcohol consumption
Becker, H. C. (2012) · Alcohol research · doi:10.35946/arcr.v34.4.09 · Cited by 172
Progress in corticotropin-releasing factor-1 antagonist development
Zorrilla, E. P., & Koob, G. F. (2010) · Drug Discovery Today · doi:10.1016/j.drudis.2010.02.011 · Cited by 167
Neurobiology of dysregulated motivational systems in drug addiction
Edwards, S., & Koob, G. F. (2010) · Future Neurology · doi:10.2217/fnl.10.14 · Cited by 157
Development of pharmacotherapies for drug addiction: a Rosetta stone approach
Koob, G. F., Kenneth Lloyd, G., & Mason, B. J. (2009) · Nature Reviews Drug Discovery · doi:10.1038/nrd2828 · Cited by 154
Escalation of drug self-administration as a hallmark of persistent addiction liability
Edwards, S., & Koob, G. F. (2013) · Behavioural Pharmacology · doi:10.1097/fbp.0b013e3283644d15 · Cited by 151
Gilpin, N. W., Karanikas, C. A., & Richardson, H. N. (2012) · PLoS ONE · doi:10.1371/journal.pone.0031466 · Cited by 146
Research on alcohol and adolescent brain development: opportunities and future directions
Witt, E. D. (2010) · Alcohol · doi:10.1016/j.alcohol.2009.08.011 · Cited by 132
Operant Behavior and Alcohol Levels in Blood and Brain of Alcohol‐Dependent Rats
Gilpin, N. W., Smith, A. D., Cole, M., Weiss, F., Koob, G. F., & Richardson, H. N. (2009) · Alcoholism Clinical and Experimental Research · doi:10.1111/j.1530-0277.2009.01051.x · Cited by 122
Heilig, M., Thorsell, A., Sommer, W. H., Hansson, A. C., Ramchandani, V. A., George, D. T., Hommer, D., & Barr, C. S. (2010) · Neuroscience & Biobehavioral Reviews · doi:10.1016/j.neubiorev.2009.11.018 · Cited by 117
How adaptation of the brain to alcohol leads to dependence: a pharmacological perspective.
Clapp, P., Bhave, S. V., & Hoffman, P. L. (2008) · PubMed Central · Cited by 116
Huang, M. M., Overstreet, D. H., Knapp, D. J., Angel, R. A., Wills, T. A., Navarro, M., Rivier, J., Vale, W., & Breese, G. R. (2009) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.109.159186 · Cited by 116
Self-citationBreese, G. R., Knapp, D. J., Overstreet, D. H., Navarro, M., Wills, T. A., & Angel, R. A. (2008) · Neuropsychopharmacology · doi:10.1038/sj.npp.1301468 · Cited by 110
Self-citationZorrilla, E. P., Heilig, M. A., de Wit, H., & Shaham, Y. (2013) · Drug and Alcohol Dependence · doi:10.1016/j.drugalcdep.2012.12.017 · Cited by 113
Neuroimmune Interface in the Comorbidity between Alcohol Use Disorder and Major Depression
Neupane, S. P. (2016) · Frontiers in Immunology · doi:10.3389/fimmu.2016.00655 · Cited by 99
Role of the Serotonergic System in Alcohol Dependence
Sari, Y., Johnson, V. R., & Weedman, J. M. (2011) · Progress in molecular biology and translational science · doi:10.1016/b978-0-12-385506-0.00010-7 · Cited by 91
Brain reward deficits accompany withdrawal (hangover) from acute ethanol in rats
Schulteis, G., & Liu, J. (2006) · Alcohol · doi:10.1016/j.alcohol.2006.06.008 · Cited by 94
Hansson, A. C., Cippitelli, A., Sommer, W. H., Ciccocioppo, R., & Heilig, M. A. (2007) · Addiction Biology · doi:10.1111/j.1369-1600.2007.00050.x · Cited by 91
Knapp, D. J., Overstreet, D. H., & Breese, G. R. (2007) · Alcoholism Clinical and Experimental Research · doi:10.1111/j.1530-0277.2007.00342.x · Cited by 85
Self-citationNeurochemical mechanisms of alcohol withdrawal
Becker, H. C., & Mulholland, P. J. (2014) · Handbook of clinical neurology · doi:10.1016/b978-0-444-62619-6.00009-4 · Cited by 88
Functional CRH variation increases stress-induced alcohol consumption in primates
Barr, C. S., Dvoskin, R. L., Gupte, M., Sommer, W. H., Sun, H., Schwandt, M. L., Lindell, S. G., Kasckow, J., Suomi, S. J., Goldman, D. A., et al. (2009) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0902863106 · Cited by 81
Sex differences in neuroadaptation to alcohol and withdrawal neurotoxicity
Sharrett-Field, L. J., Butler, T. R., Reynolds, A. R., Berry, J. N., & Prendergast, M. (2013) · Pflügers Archiv - European Journal of Physiology · doi:10.1007/s00424-013-1266-4 · Cited by 80
Lowery, E., & Thiele, T. E. (2010) · CNS & Neurological Disorders - Drug Targets · doi:10.2174/187152710790966605 · Cited by 71
Pastor, R., McKinnon, C. S., Scibelli, A. C., Burkhart‐Kasch, S., Reed, C. L., Ryabinin, A. E., Coste, S. C., Stenzel‐Poore, M. P., & Phillips, T. J. (2008) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0710181105 · Cited by 67
Walker, B. M., Drimmer, D. A., Walker, J. L., Liu, T., Mathé, A. A., & Ehlers, C. L. (2010) · Alcohol · doi:10.1016/j.alcohol.2010.06.006 · Cited by 64
Knapp, D. J., Whitman, B. A., Wills, T. A., Angel, R. A., Overstreet, D. H., Criswell, H. E., Ming, Z., & Breese, G. R. (2011) · Brain, Behavior, and Immunity · doi:10.1016/j.bbi.2011.02.018 · Cited by 60
“…of ethanol exposure and withdrawal, support the idea that progressively worsening profiles of withdrawal-like states arise and may persist over time to render subjects vulnerable to future environmental stressors and challenges (Breese et al., 2005b; Overstreet et al., 2002; Valdez et al., 2002).”
BackgroundMethodInfluentialSelf-citationWills, T. A., Knapp, D. J., Overstreet, D. H., & Breese, G. R. (2008) · Alcoholism Clinical and Experimental Research · doi:10.1111/j.1530-0277.2008.00856.x · Cited by 60
Self-citationCorticotropin-Releasing Factor (CRF) and Addictive Behaviors
Roberto, M., Spierling, S. R., Kirson, D., & Zorrilla, E. P. (2017) · International review of neurobiology · doi:10.1016/bs.irn.2017.06.004 · Cited by 62
Williams, A. M., Reis, D. J., Powell, A. S., Neira, L. J., Nealey, K. A., Ziegler, C. E., Kloss, N. D., Bilimoria, J. L., Smith, C. E., & Walker, B. M. (2012) · Psychopharmacology · doi:10.1007/s00213-012-2691-3 · Cited by 56
Wolitzky-Taylor, K. B., Operskalski, J. T., Ries, R., Craske, M., & Roy-Byrne, P. (2011) · Journal of addiction medicine · doi:10.1097/adm.0b013e31823276d7 · Cited by 47
Belmer, A., Patkar, O. L., Lanoue, V., & Bartlett, S. E. (2018) · Scientific Reports · doi:10.1038/s41598-018-20504-z · Cited by 48
Phillips, T. J., Reed, C. L., & Pastor, R. (2015) · Genes Brain & Behavior · doi:10.1111/gbb.12189 · Cited by 46
Brain pathways to recovery from alcohol dependence
Cui, C., Noronha, A., Warren, K. R., Koob, G. F., Sinha, R., Thakkar, M. M., Matochik, J. A., Crews, F. T., Chandler, L. J., Adolf Pfefferbaum, A., et al. (2015) · Alcohol · doi:10.1016/j.alcohol.2015.04.006 · Cited by 49
Mejía-Toiber, J., Boutros, N., Markou, A., & Semenova, S. (2014) · Behavioural Brain Research · doi:10.1016/j.bbr.2014.02.019 · Cited by 49
Ayanwuyi, L. O., Carvajal, F., Lerma-Cabrera, J. M., Domi, E., Björk, K., Ubaldi, M., Heilig, M. A., Roberto, M., Ciccocioppo, R., & Cippitelli, A. (2013) · Frontiers in Psychiatry · doi:10.3389/fpsyt.2013.00023 · Cited by 44
Knapp, D. J., Harper, K. M., Whitman, B. A., Zimomra, Z. R., & Breese, G. R. (2016) · Brain Sciences · doi:10.3390/brainsci6030025 · Cited by 43
Self-citationKoob, G. F., & Vendruscolo, L. F. (2023) · Current topics in behavioral neurosciences · doi:10.1007/7854_2023_424 · Cited by 46
Serotonergic Neuroplasticity in Alcohol Addiction
Belmer, A., Patkar, O. L., Pitman, K. M., & Bartlett, S. E. (2015) · Brain Plasticity · doi:10.3233/bpl-150022 · Cited by 42
An Update on CRF Mechanisms Underlying Alcohol Use Disorders and Dependence
Quadros, I. M., Macedo, G. C., Domingues, L. P., & Favoretto, C. A. (2016) · Frontiers in Endocrinology · doi:10.3389/fendo.2016.00134 · Cited by 45
Läck, A. K., Christian, D., Diaz, M. R., & McCool, B. A. (2009) · Alcohol · doi:10.1016/j.alcohol.2008.11.002 · Cited by 42
Buck, H. M., Hueston, C. M., Bishop, C., & Terrence Deak, B. (2011) · Psychopharmacology · doi:10.1007/s00213-011-2388-z · Cited by 41
Endocannabinoid signaling in neurotoxicity and neuroprotection
Pope, C., Mechoulam, R., & Parsons, L. H. (2009) · NeuroToxicology · doi:10.1016/j.neuro.2009.12.002 · Cited by 40
A selective ALDH-2 inhibitor reduces anxiety in rats
Overstreet, D. H., Knapp, D. J., Breese, G. R., & Diamond, I. (2009) · Pharmacology Biochemistry and Behavior · doi:10.1016/j.pbb.2009.09.004 · Cited by 40
Self-citationGilpin, N. W. (2012) · Neuropeptides · doi:10.1016/j.npep.2012.08.001 · Cited by 41
Episodic Withdrawal Promotes Psychomotor Sensitization to Morphine
Rothwell, P. E., Gewirtz, J. C., & Thomas, M. J. (2010) · Neuropsychopharmacology · doi:10.1038/npp.2010.134 · Cited by 39
Zamora-Martinez, E. R., & Edwards, S. (2014) · Frontiers in Integrative Neuroscience · doi:10.3389/fnint.2014.00024 · Cited by 37
Wills, T. A., Knapp, D. J., Overstreet, D. H., & Breese, G. R. (2008) · Alcoholism Clinical and Experimental Research · doi:10.1111/j.1530-0277.2008.00709.x · Cited by 36
Self-citationPrendergast, M., & Mulholland, P. J. (2011) · Addiction Biology · doi:10.1111/j.1369-1600.2011.00375.x · Cited by 37
Knapp, D. J., Overstreet, D. H., Angel, R. A., Navarro, M., & Breese, G. R. (2007) · Alcoholism Clinical and Experimental Research · doi:10.1111/j.1530-0277.2007.00514.x · Cited by 34
Self-citationVasopressin and alcohol: a multifaceted relationship
Harper, K. M., Knapp, D. J., Criswell, H. E., & Breese, G. R. (2018) · Psychopharmacology · doi:10.1007/s00213-018-5099-x · Cited by 35
Self-citationGammie, S. C., & Stevenson, S. A. (2006) · Stress · doi:10.1080/10253890600969106 · Cited by 33
Interactions of Stress and CRF in Ethanol‐Withdrawal Induced Anxiety in Adolescent and Adult Rats
Wills, T. A., Knapp, D. J., Overstreet, D. H., & Breese, G. R. (2010) · Alcoholism Clinical and Experimental Research · doi:10.1111/j.1530-0277.2010.01245.x · Cited by 33
Self-citationHomer2 regulates alcohol and stress cross-sensitization
Quadir, S. G., dos Santos, J. R. B., Campbell, R. R., Wroten, M. G., Singh, N., Holloway, J. J., Bal, S. K., Camarini, R., & Szumlinski, K. K. (2015) · Addiction Biology · doi:10.1111/adb.12252 · Cited by 37
Biobehavioral Interactions Between Stress and Alcohol
Weera, M. M. (2019) · Alcohol research · doi:10.35946/arcr.v40.1.04 · Cited by 32
Genetic Variation and Brain Gene Expression in Rodent Models of Alcoholism
Björk, K., Hansson, A. C., & Sommer, W. H. (2010) · International review of neurobiology · doi:10.1016/s0074-7742(10)91005-2 · Cited by 32
Knapp, D. J., Overstreet, D. H., Huang, M. M., Wills, T. A., Whitman, B. A., Angel, R. A., Sinnett, S. E., & Breese, G. R. (2011) · Psychopharmacology · doi:10.1007/s00213-011-2366-5 · Cited by 32
Self-citationAlcohol dose effects on stress response to cued threat vary by threat intensity
Moberg, C. A., Weber, S. M., & Curtin, J. J. (2011) · Psychopharmacology · doi:10.1007/s00213-011-2304-6 · Cited by 27
Rasmussen, D. D., Kincaid, C., & Froehlich, J. C. (2016) · Alcohol and Alcoholism · doi:10.1093/alcalc/agw082 · Cited by 28
Albrechet‐Souza, L., Viola, T. W., Grassi‐Oliveira, R., Miczek, K. A., & de Almeida, R. M. M. (2017) · Frontiers in Pharmacology · doi:10.3389/fphar.2017.00762 · Cited by 29
Tanaka, K., Kunishige-Yamamoto, A., Hashimoto, H., Shintani, N., Hayata, A., & Baba, A. (2009) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2009.11.136 · Cited by 24
Barkley‐Levenson, A. M., & Crabbe, J. C. (2014) · Alcohol · doi:10.1016/j.alcohol.2014.07.022 · Cited by 22
Morisot, N., Moine, C. L., Millan, M. J., & Contarino, A. (2014) · The International Journal of Neuropsychopharmacology · doi:10.1017/s1461145714000625 · Cited by 21
Morisot, N., Monier, R., Moine, C. L., Millan, M. J., & Contarino, A. (2018) · British Journal of Pharmacology · doi:10.1111/bph.14159 · Cited by 26
Harper, K. M., Knapp, D. J., Butler, R. K., Cook, C. A., Criswell, H. E., Stuber, G. D., & Breese, G. R. (2019) · Alcoholism Clinical and Experimental Research · doi:10.1111/acer.14163 · Cited by 21
Self-citationNeira, S., Hassanein, L. A., Stanhope, C. M., Buccini, M. C., D’Ambrosio, S., Flanigan, M. E., Haun, H. L., Boyt, K. M., Bains, J. S., & Kash, T. L. (2022) · Alcoholism Clinical and Experimental Research · doi:10.1111/acer.14901 · Cited by 21
Ming, Z., Criswell, H. E., & Breese, G. R. (2013) · Brain Behavior and Immunity · doi:10.1016/j.bbi.2013.06.001 · Cited by 18
Self-citationHow Adaptation of the Brain to Alcohol Leads to Dependence
Clapp, P., Bhave, S. V., Hoffman, P. L., & de Paula, L. F. (2008) · Cited by 18
Maldonado‐Devincci, A. M., Kampov-Polevoi, A., McKinley, R. E., Morrow, D., O’Buckley, T. K., & Morrow, A. L. (2016) · Frontiers in Cellular Neuroscience · doi:10.3389/fncel.2016.00040 · Cited by 17
Breese, G. R., & Knapp, D. J. (2016) · Alcohol · doi:10.1016/j.alcohol.2016.01.005 · Cited by 16
Self-citationMorisot, N., & Contarino, A. (2016) · Neuropharmacology · doi:10.1016/j.neuropharm.2016.02.021 · Cited by 16
Reilly, M. T., Noronha, A., & Warren, K. R. (2014) · Handbook of clinical neurology · doi:10.1016/b978-0-444-62619-6.00002-1 · Cited by 18
Koob, G. F., & Moal, M. L. (2006) · Elsevier eBooks · doi:10.1016/b978-012419239-3/50042-4 · Cited by 15
Can CRF1receptor antagonists become antidepressant and/or anxiolytic agents?
Overstreet, D. H., Knapp, D. J., & Breese, G. R. (2005) · Drug Development Research · doi:10.1002/ddr.20023 · Cited by 14
Self-citationHarper, K. M., Knapp, D. J., Park, M. A., & Breese, G. R. (2016) · Psychopharmacology · doi:10.1007/s00213-016-4439-y · Cited by 13
Self-citationEmerging targets for addiction neuropharmacology
Ubaldi, M., Cannella, N., & Ciccocioppo, R. (2015) · Progress in brain research · doi:10.1016/bs.pbr.2015.07.018 · Cited by 11
Animal Models of Drug Dependence: Motivational Perspective
Koob, G. F. (2010) · Springer eBooks · doi:10.1007/978-1-4419-0338-9_15 · Cited by 10
Metadata
- Authors
- Breese, G. R., Overstreet, D. H., Knapp, D. J., & Navarro, M.
- Affiliations
- University of North Carolina at Chapel Hill (US)
- Corresponding author
- Breese, George R
- Venue
- Neuropsychopharmacology
- Published
- 2005-02-23
- Volume
- 30
- Issue
- 9
- Pages
- 1662-1669
- ISSN
- 0893-133X (ISSN-L)
- 1740-634X
- PMC
- PMC2864139
- OpenAlex
- W1979024772
- Cited by
- 124
- References
- 41
- Citations by year
- 2025: 2 · 2023: 4 · 2022: 2 · 2021: 1 · 2020: 3 · 2019: 7 · 2018: 4 · 2017: 3 · 2016: 10 · 2015: 6 · 2014: 10 · 2013: 8 · 2012: 6
- FWCI
- 2.54
- Type
- journal article
- Language
- en
- Open access
- bronze
- doi.org
- Licence
- www.springer.com/tdm (tdm)
- Locations
- Neuropsychopharmacology (publishedVersion)
- PubMed (publishedVersion)
- PubMed Central (acceptedVersion)
- Carolina Digital Repository (University of North Carolina at Chapel Hill) (submittedVersion)
- UNC Libraries
- Funders
- National Institute on Alcohol Abuse and Alcoholism (R01AA014284, AA-14284, P50AA011605, AA 11605, R01AA014949, AA 14949, P60AA011605)
- Topics
- Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Neurotransmitter Receptor Influence on Behavior
- Life Sciences › Neuroscience › Behavioral Neuroscience › Stress Responses and Cortisol
- Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Neuropeptides and Animal Physiology
- Keywords
- ethanol withdrawal, stress-induced anxiety, restraint stress, social interaction, CRF1 receptor antagonist, benzodiazepine antagonists, 5-HT1A receptor agonist, alcohol craving, relapse, alcoholism
- MeSH terms
- Ethanol, Analysis of Variance, Animals, Anxiety, Behavior, Animal, Buspirone, Central Nervous System Depressants, Drug Interactions, Flumazenil, Food, Formulated, Interpersonal Relations, Male, Pyrimidines, Pyrroles, Restraint, Physical, Stress, Psychological, Substance Withdrawal Syndrome, Time Factors, Anti-Anxiety Agents, Rats, Sprague-Dawley, Serotonin Receptor Agonists, Receptors, Corticotropin-Releasing Hormone, GABA Modulators, Rats
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review